A structured framework for evaluating payer mix quality, physician dependency risk, billing compliance, and patient retention before acquiring a podiatry practice.
Acquiring a podiatry practice in the $1M–$5M revenue range requires diligence that goes well beyond standard small business checks. Because revenue often concentrates in a single physician whose Medicare credentialing, referral relationships, and clinical reputation drive patient volume, buyers must rigorously assess what earnings will look like post-transition. This checklist covers five critical areas: financial quality and reimbursement sustainability, physician and staff retention risk, billing and coding compliance, healthcare regulatory exposure, and patient volume stability. Work through every item before submitting an LOI, and engage a healthcare M&A attorney familiar with Stark Law and your state's corporate practice of medicine rules before structuring the deal.
Verify the true earnings power of the practice and assess reimbursement sustainability across all payer categories.
Request 3 years of tax returns, P&Ls, and collection reports reconciled to bank statements.
Owner compensation addbacks are common; clean reconciliation reveals true EBITDA available to a new owner.
Red flag: Unexplained revenue gaps between tax returns and internal P&Ls indicate possible income manipulation.
Analyze payer mix by percentage of collections: Medicare, Medicaid, commercial, and self-pay.
Medicare concentration above 60% limits reimbursement upside and increases policy change exposure.
Red flag: Medicare and Medicaid combined exceeding 70% of total collections signals reimbursement ceiling risk.
Pull accounts receivable aging report segmented by payer and days outstanding.
Aged AR over 120 days signals collection problems that reduce net purchase consideration.
Red flag: More than 20% of AR aged beyond 90 days suggests systemic billing or credentialing failures.
Identify all owner personal expenses and one-time charges run through the practice.
Normalizing EBITDA requires removing non-recurring and personal costs to price the deal accurately.
Red flag: Vague or undocumented addbacks exceeding 15% of stated EBITDA should trigger independent verification.
Assess the risk of revenue loss if the selling physician departs and structure appropriate transition protections.
Review the selling physician's employment or ownership agreement, non-compete, and any existing restrictive covenants.
Unenforceable or absent non-competes allow the departing physician to open a competing practice nearby.
Red flag: No post-closing employment agreement or non-compete in place is a critical deal-structure failure.
Quantify what percentage of collections are directly attributable to the selling physician versus associates.
100% physician revenue concentration means the business may not survive a clean owner exit.
Red flag: Seller generating more than 80% of collections with no associate coverage is a major retention risk.
Evaluate associate podiatrist agreements, compensation structures, and remaining contract terms.
Associates who depart post-close can cause immediate revenue decline and patient disruption.
Red flag: Associate agreements expiring within 12 months of closing without renewal clauses warrant renegotiation.
Confirm proposed earnout or transition terms align with patient retention metrics and revenue milestones.
Earnouts tied to collections protect buyers if the seller's departure causes patient attrition.
Red flag: Seller refusing any earnout or transition employment in a physician-dependent practice is a serious red flag.
Identify billing vulnerabilities, coding accuracy issues, and any existing Medicare or payer audit exposure.
Audit CPT code utilization patterns for the top 10 billed codes against Medicare national benchmarks.
Outlier coding rates for routine foot care or diabetic nail debridement trigger CMS audits and overpayment demands.
Red flag: Billing frequency for high-volume codes exceeding 2x the national average indicates potential upcoding exposure.
Request documentation of any past RAC audits, Medicare overpayment notices, or payer recoupments.
Unresolved overpayment demands or pending audits become buyer liability in an asset purchase.
Red flag: Any undisclosed Medicare overpayment demand or active CMS audit is an immediate deal-stopper.
Review claim denial rates by payer and assess the practice's denial management and appeals process.
High denial rates reduce net collections and signal documentation or credentialing failures.
Red flag: Denial rates exceeding 10% across major payers without an active appeals workflow destroy revenue cycle value.
Confirm all providers have current Medicare and Medicaid enrollment numbers and credentialing is up to date.
Lapsed credentialing creates billing gaps that can halt cash flow during transition.
Red flag: Any provider billing under a lapsed or mismatched NPI number exposes the buyer to False Claims Act liability.
Confirm the practice is structurally compliant with HIPAA, Stark Law, anti-kickback statutes, and state licensing requirements.
Verify all state podiatric licenses, DEA registrations, and facility permits are current and transferable.
Unlicensed or lapsed registrations can shut down operations on day one post-close.
Red flag: Any provider with a lapsed license, board complaint, or DEA restriction is a critical pre-close remediation issue.
Assess the deal structure for compliance with your state's corporate practice of medicine doctrine.
Many states prohibit non-physicians from owning or controlling a medical practice without a compliant management agreement.
Red flag: Non-physician buyer pursuing direct ownership in a CPOM-restricted state without legal workaround is unexecutable.
Review all referral arrangements, co-management agreements, and any ancillary service relationships for Stark Law compliance.
Improper physician self-referral arrangements expose both seller and buyer to False Claims Act penalties.
Red flag: Undisclosed financial relationships with referring physicians or hospitals without documented Stark exceptions is a deal risk.
Review HIPAA policies, Business Associate Agreements, and any prior breach notification history.
Undisclosed data breaches or missing BAAs transfer liability to the buyer and can trigger HHS investigations.
Red flag: Any unreported HIPAA breach or missing BAA with an EHR vendor or billing company requires immediate remediation.
Evaluate the durability of patient demand and whether goodwill is transferable beyond the selling physician.
Analyze monthly patient visit volume trends over 36 months, segmented by active vs. new patients.
Declining new patient volume signals referral erosion or market saturation before the sale.
Red flag: New patient volume declining more than 15% year-over-year for two consecutive years signals demand deterioration.
Map all referral sources by volume and determine whether relationships are physician-level or practice-level.
Referrals tied exclusively to the selling physician will likely migrate with them post-exit.
Red flag: Top 3 referral sources accounting for over 50% of new patients with no associate relationship is a concentration risk.
Assess the active diabetic foot care and wound care patient panel for recurring appointment frequency.
Chronic care patients represent stable, recurring revenue that survives physician transitions better than episodic cases.
Red flag: Fewer than 200 active diabetic care patients in the panel suggests limited recurring revenue base.
Review the EHR system, patient recall program, and scheduling infrastructure for operational continuity.
An outdated or non-transferable EHR requires costly replacement that erodes post-close cash flow.
Red flag: EHR system end-of-life or vendor discontinuation notice in place at time of LOI requires immediate capital budget adjustment.
Find Podiatry Practice Businesses For Sale
Vetted targets with diligence packages — skip the cold search.
Podiatry practices in the lower middle market typically trade at 3x–5.5x EBITDA. Practices with associate coverage, diversified payer mix, and strong referral networks command the upper end of that range. Single-physician practices with heavy Medicare concentration and no transition plan will price closer to 3x–3.5x. SBA financing generally supports deals up to 4x–4.5x EBITDA when normalized earnings are well-documented.
Start by mapping what percentage of collections come from the selling physician versus associates or mid-level providers. Then analyze whether top referral sources have relationships with the practice as an entity or specifically with the departing physician. A structured 12–24 month transition employment agreement with the seller, combined with earnout provisions tied to patient retention, is the most effective way to protect against post-close revenue erosion.
The highest-risk area in podiatry billing is routine foot care and diabetic nail debridement coding under Medicare. Overutilization of CPT codes 11721 and 11055–11057 relative to national benchmarks is a common CMS audit trigger. Request a 3-year claims history, benchmark utilization rates against Medicare data, and look for any prior RAC audit findings, overpayment demands, or commercial payer recoupments. Unresolved billing exposure can transfer to the buyer in an asset purchase if not properly indemnified.
Yes, but the structure depends on your state's corporate practice of medicine laws. In CPOM-restricted states, a non-physician buyer typically establishes a Management Services Organization that contracts with a physician-owned professional entity for clinical services. In states with no CPOM restrictions, direct ownership is permissible. Engage a healthcare M&A attorney in the target practice's state before finalizing any deal structure, as violating CPOM statutes can void the transaction or expose the buyer to regulatory penalties.
More Podiatry Practice Guides
More Due Diligence Checklists
Stop cold-searching. Find signal-scored Podiatry Practice targets with seller motivation already identified.
Create your free accountNo credit card required
For Buyers
For Sellers